EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections

Wisse van Os iD, Alina Nussbaumer-Pröll iD, Anh Duc Pham, Gert-Jan Wijnant, Perrin Ngougni Pokem, Françoise Van Bambeke iD, J G Coen van Hasselt iD, Markus Zeitlinger iD

Journal of Antimicrobial Chemotherapy · 01.10.2024 · 79 (10) · 2484-2492

DOI: 10.1093/jac/dkae243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 20.07.2024. Verfasst von Wisse van Os und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli, Penicillins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's H2020 Marie Skłodowska-Curie Actions, European Union’s H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temocillin is increasingly considered as an alternative to carbapenems. However, there is no consensus on optimal dosing strategies and limited data on temocillin efficacy in systemic infections.

Objectives

We compared temocillin dosing strategies using pharmacokinetic/pharmacodynamic (PK/PD) modelling and simulation based on plasma exposure and in vitro time–kill data.

Methods

Temocillin effects on four Escherichia coli strains were evaluated using static time–kill experiments and the hollow-fibre infection model, in which unbound plasma concentrations following intermittent and continuous infusion regimens of 4 and 6 g daily were replicated over 72 h. A PK/PD model was developed to describe the time–kill data. The PK/PD model was coupled to a population PK model of temocillin in critically ill patients to predict bacterial killing and resistance development following various dosing regimens.

Results

Amplification of resistant subpopulations was observed within 24 h for all strains. The PK/PD model described the observed bacterial kill kinetics and resistance development from both experimental systems well. Simulations indicated dose-dependent bacterial killing within and beyond the currently used daily dose range, and a superiority of continuous compared with intermittent infusions. However, regrowth of resistant subpopulations was frequently observed. For two strains, bacteriostasis over 72 h was predicted only with doses that are higher than those currently licensed.

Conclusions

Continuous infusions and 6 g daily doses of temocillin kill E. coli more effectively than 4 g daily doses and intermittent infusions, and may increase efficacy in the treatment of systemic infections. However, higher daily doses may be required to suppress resistance development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEscherichia coliPenicillinsHumansMicrobial Sensitivity TestsEscherichia coli InfectionsMicrobial Viability

Substanzen

temocillinAnti-Bacterial AgentsPenicillins

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
  • Division of Systems Pharmacology & Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
  • Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain, Avenue E. Mounier 73/B1.73.05, 1200 Brussels, Belgium.

ORCID-Profile: Wisse van Os, Alina Nussbaumer-Pröll, Françoise Van Bambeke, J G Coen van Hasselt, Markus Zeitlinger

Förderung

  • European Union's H2020 Marie Skłodowska-Curie Actions
  • European Union’s H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

van Os, W., Nussbaumer-Pröll, A., Pham, A. D., Wijnant, G. J., Ngougni Pokem, P., Van Bambeke, F., van Hasselt, J. G. C., & Zeitlinger, M. (2024). Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections. Journal of Antimicrobial Chemotherapy, 79(10), 2484-2492. https://doi.org/10.1093/jac/dkae243

Vancouver

van Os W, Nussbaumer-Pröll A, Pham AD, Wijnant GJ, Ngougni Pokem P, Van Bambeke F, et al. Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections. Journal of Antimicrobial Chemotherapy. 2024;79(10):2484-2492. doi:10.1093/jac/dkae243

BibTeX
@article{vanOs2024,
  author = {van Os, Wisse and Nussbaumer-Pröll, Alina and Pham, Anh Duc and Wijnant, Gert-Jan and Ngougni Pokem, Perrin and Van Bambeke, Françoise and van Hasselt, J G Coen and Zeitlinger, Markus},
  title = {Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {10},
  pages = {2484--2492},
  doi = {10.1093/jac/dkae243}
}
Kostenlos starten →